All research
2026-06-27 PubMed

Combined *Schistosoma mansoni* infection and alcohol abuse severely worsen hepatic damage and oxidative stress

Hepatic, oxidative, and immunological alterations in adults with concomitant Schistosoma mansoni infection and alcohol abuse in an endemic area of Cameroon.

Background

Schistosoma mansoni infection and chronic alcohol abuse are global health burdens, particularly impacting liver health. While both conditions independently cause significant hepatic damage, the synergistic effects of their co-occurrence remain poorly understood. Current interventions often target these conditions separately, leaving a gap in understanding and managing the compounded pathophysiological mechanisms when they coexist. This study addresses this by investigating the combined hepatic, oxidative, and immunological alterations in co-exposed individuals.

Study Design

A cross-sectional analytical study was conducted in Makenéné, Cameroon, involving 310 adults stratified by parasitic status and alcohol exposure. Schistosoma mansoni infection was diagnosed using Kato-Katz and POC-CCA assays. Alcohol exposure was assessed via the Alcohol Use Disorders Identification Test (AUDIT). Researchers evaluated hematological, liver function (e.g., AST, ALT, GGT, ALP), oxidative stress (e.g., malondialdehyde, catalase, GSH, nitrite), inflammatory (TNF-α), and fibrogenic (TGF-β1, P3NP) profiles.

Results

Combined S. mansoni infection and alcohol abuse significantly exacerbated liver damage, showing elevated AST (p < 0.001), ALP (p < 0.01), GGT (p < 0.05), and AST/ALT ratio (p < 0.001) compared to alcohol abuse alone. Relative to schistosomiasis alone, the comorbidity led to higher ALT and AST (p < 0.01) and GGT (p < 0.05), alongside lower total protein (p < 0.05). Both conditions independently induced oxidative stress, marked by increased malondialdehyde (p < 0.001) and decreased catalase, GSH, and nitrite. This oxidative imbalance was further worsened in co-exposed individuals, who exhibited the lowest catalase activity (p < 0.01) and GSH concentration (p < 0.05). Immunologically, the comorbidity featured the lowest TNF-α levels (p < 0.05) but the highest TGF-β1 levels (p < 0.001). Procollagen type III N-terminal peptide (P3NP) peaked during S. mansoni infection (p < 0.001) but was less expressed during the comorbidity (p < 0.05).

Why It Matters

This study highlights that concomitant Schistosoma mansoni infection and alcohol abuse create a uniquely severe hepatic pathology, distinct from either condition alone. For clinicians in endemic regions, this suggests that managing patients with both conditions requires a more aggressive or tailored approach, potentially focusing on enhanced antioxidant support and careful monitoring of fibrogenic markers like TGF-β1. The observed suppression of TNF-α alongside elevated TGF-β1 indicates a complex immunological shift towards fibrosis, which could inform future therapeutic strategies. This research underscores the need for integrated public health interventions that address both parasitic infections and alcohol abuse concurrently to mitigate severe liver outcomes.


Source: pubmed:42363080 · Ingested 2026-06-27 · Digest: gemini-2.5-flash